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Abstract
We report here on the cloning and functional characterization of the third subtype of amino acid transport system A,
designated ATA3 (amino acid transporter A3), from a human liver cell line. This transporter consists of 547 amino acids and
is structurally related to the members of the glutamine transporter family. The human ATA3 (hATA3) exhibits 88% identity
in amino acid sequence with rat ATA3. The gene coding for hATA3 contains 16 exons and is located on human chromosome
12q13. It is expressed almost exclusively in the liver. hATA3 mediates the transport of neutral amino acids including K-
(methylamino)isobutyric acid (MeAIB), the model substrate for system A, in a Na-coupled manner and the transport of
cationic amino acids in a Na-independent manner. The affinity of hATA3 for cationic amino acids is higher than for neutral
amino acids. The transport function of hATA3 is thus similar to that of system yL. The ability of hATA3 to transport
cationic amino acids with high affinity is unique among the members of the glutamine transporter family. hATA1 and
hATA2, the other two known members of the system A subfamily, show little affinity toward cationic amino acids. hATA3
also differs from hATA1 and hATA2 in exhibiting low affinity for MeAIB. Since liver does not express any of the previously
known high-affinity cationic amino acid transporters, ATA3 is likely to provide the major route for the uptake of arginine in
this tissue. ß 2001 Elsevier Science B.V. All rights reserved.
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Transport of cationic amino acids in mammalian cells is mediated by a multitude of transport systems
[1^4]. Several of these transport systems have been
cloned and functionally characterized. Based on
functional characteristics, these transport systems
fall into four distinct categories: (a) the members
of the cationic amino acid transporter family
CAT1^4, (b) the transporter b0; that is known to
be associated with the genetic disorder cystinuria,
(c) the transporter yL that is related to the genetic
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disorder lysinuric protein intolerance, and (d) the
transporter B0;. The cationic amino acid transport-
ers CAT1^4 mediate Na-independent transport of
cationic amino acids. These transporters, with the
exception of CAT1, have little or no a⁄nity for neu-
tral amino acids [1^4]. CAT1 is capable of interact-
ing with certain neutral amino acids in the presence
of Na [5]. b0; is a heterodimeric transporter con-
sisting of b0;AT and rBAT [6^9] or b0;AT and
4F2hc [6,10] that mediates the transport of cationic
amino acids as well as neutral amino acids in the
absence of Na. yL is also a heterodimeric trans-
porter consisting of yLAT1 and 4F2hc or yLAT2
and 4F2hc, but it transports cationic amino acids in
a Na-independent manner and neutral amino acids
in a Na-dependent manner [11^14]. B0; belongs to
the neurotransmitter transporter family and it trans-
ports cationic amino acids as well as neutral amino
acids in a Na- and Cl3-coupled manner [15].
Recent cloning studies have identi¢ed a new amino
acid transporter family, the members of which medi-
ate Na-coupled transport of glutamine. This gluta-
mine transporter family consists of two subtypes,
system N and system A. Two members of the system
N subtype have been identi¢ed. They are system SN1
[16^18] and system SN2 (T. Nakanishi et al., unpub-
lished). There are also three members in the system A
subfamily: ATA1 [19,20], ATA2 [21^24] and ATA3
[25]. SN1 and SN2 mediate the Na- and H-depen-
dent transport of neutral amino acids. The transport
mechanism involves the movement of Na and the
amino acid substrate in one direction in exchange for
H on the trans-side and the Na :amino acid:H
stoichiometry is 2:1:1. ATA1, ATA2 and ATA3
also mediate the Na-dependent transport of neutral
amino acids. Though the transport function of
ATA1, ATA2 and ATA3 is strongly in£uenced by
intracellular pH, there is no movement of H asso-
ciated with the transport process. The Na :amino
acid stoichiometry is 1:1. These two subfamilies
can be di¡erentiated not only on the basis of the
involvement of H in the transport mechanism but
also on the basis of interaction with the model amino
acid substrate K-(methylamino)isobutyric acid
(MeAIB) [26]. SN1 and SN2 do not recognize
MeAIB as a substrate whereas ATA1, ATA2 and
ATA3 do. In fact, the Na-dependent transport of
MeAIB is a distinguishing characteristic of the sys-
tem A subfamily. There is no evidence in the litera-
ture for the interaction of system N or system A with
cationic amino acids [2^4]. This is supported by re-
cent studies with cloned SN1, SN2, ATA1, and
ATA2 [16^24]. There is no information available cur-
rently on whether or not ATA3, the newest member
of the glutamine transporter family to be identi¢ed,
interacts with cationic amino acids. Here we report
on the cloning of human ATA3 and on the ability of
the transporter to interact with cationic amino acids.
The HepG2 cell cDNA library [22] was screened
under high stringency conditions using 32P-labeled
rat ATA3 cDNA [25] as the probe. Two positive
clones were obtained and they were analyzed for
their restriction fragment pattern. Both clones were
found to be identical. One of these clones was se-
lected for sequence and functional analyses. Both
sense and antisense strands of the cDNA were se-
quenced using an automated Perkin-Elmer Applied
Biosystems 377 Prism DNA sequencer. The sequence
was analyzed using the GCG sequence analysis soft-
ware package GCG version 10 (Genetics Computer
Group, Madison, WI, USA).
The functional expression of the cloned transport-
er was done in human retinal pigment epithelial
(HRPE) cells using the vaccinia virus expression sys-
tem as described previously [6,10,17,20^22]. Trans-
port measurements were made at 37‡C for 15 min
with [14C]MeAIB, [3H]glycine, or [3H]arginine as a
substrate. The transport bu¡er in most experiments
was 25 mM Tris/HEPES (pH 8.5) containing 140
mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, and 5 mM glucose. When the in£uence of
pH on transport was studied, bu¡ers of varying pH
were prepared by appropriately mixing the following
two bu¡ers: 25 mM Tris/HEPES (pH 9.0) and 25
mM MES/Tris (pH 5.5), both containing 140 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4,
and 5 mM glucose. When the in£uence of Na on
transport was assessed, a Na-free bu¡er was pre-
pared by isoosmotically substituting N-methyl-D-
glucamine (NMDG) chloride for NaCl. Endogenous
transport was always determined in parallel using
cells transfected with vector alone. cDNA-speci¢c
transport was calculated by adjusting for the endog-
enous activity. The kinetic parameter Michaelis-
Menten constant (Kt) was calculated by ¢tting the
cDNA-speci¢c transport data to the Michaelis-Men-
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ten equation describing a single saturable system.
Analysis was done by non-linear regression, and
the resultant value was con¢rmed by linear regres-
sion.
A commercially available human multiple tissue
blot (Origene, Rockville, MD, USA) was used to
determine the tissue expression pattern of the cloned
cDNA. The blot was hybridized sequentially under
high stringency conditions ¢rst with 32P-labeled
hATA3 cDNA and then with 32P-labeled glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) cDNA.
The hATA3 cDNA is 3965 bp long and contains
an open reading frame (nucleotide positions 365^
2008) (GenBank accession No. AF305814). The
cDNA codes for a protein of 547 amino acids. The
amino acid sequence of this protein shows signi¢cant
homology to that of rat ATA3 [25] (88% identity),
human ATA1 [20] (47% identity) and human ATA2
[22] (57% identity). The homology with the other two
members of the glutamine transporter family, human
SN1 [17] and human SN2 (T. Nakanishi et al., un-
published), is also signi¢cant (56% identity with hu-
man SN1 and 51% identity with human SN2).
hATA3 consists of the highest number of amino
acids among the members of the system A subfamily
(547 amino acids in hATA3 versus 487 amino acids
in hATA1 and 506 amino acids in hATA2). The
extra amino acids in hATA3 are located exclusively
in the middle of the protein. The three proteins show
marked diversity in amino acid sequence in their
amino termini. Hydropathy analysis of the amino
acid sequence suggests the presence of 10^11 putative
transmembrane domains in hATA3. These structural
features of hATA3 are similar to those of rat ATA3
recently reported from our laboratory [25].
A GenBank database search with the nucleotide
sequence of hATA3 cDNA revealed that the human
gene coding for this protein has been completely se-
quenced (GenBank accession Nos. AC005854 and
AC008014). The gene is located on chromosome
12q13. The gene is approx. 40 kb long. By aligning
the nucleotide sequence of the cloned hATA3 cDNA
with the genomic sequence, we were able to deduce
the exon-intron organization of the gene. The gene
consists of 16 exons and 15 introns. The size of each
of the exons and introns and the nucleotide sequen-
ces of the splice junctions are given in Table 1. The
5P- and 3P-termini of each intron possess the consen-
sus sequence for RNA splicing (gt/ag). The transla-
tion start site ATG is located in exon 2 and the
translation termination site TAA is located in exon
16. Exon 1 does not code for the protein.
Northern analysis with a multiple human tissue
blot shows that ATA3 is expressed almost exclusively
in the liver (Fig. 1). ATA3 mRNA is detectable in
the kidney, but the levels are severalfold lower com-
Table 1
Exon-intron organization of the human ata3 gene
Exon Intron Exon
No. Size (bp) 3P junction 5P junction Size (bp) No. 3P junction 5P junction No.
1 194 ...AATAATTAAG gtacagctgt... 10 409 1 ...ctgtttgcag AACAGAGTGT... 2
2 231 ...CAATGAGCAG gtatggggtt... 4 334 2 ...gtgtgttcag TCAATTTGCT... 3
3 91 ...TGATGAACAC gtaagtgaat... 496 3 ...ctttttcaag CATCCCGGAA... 4
4 116 ...TACTTTTTAT gtaagtgaat 2 738 4 ...ccctttgcag AATCATGCTG... 5
5 74 ...AAGGAAGGAG gtatgctacc... 469 5 ...ttgattgtag GGTCTTTGAT... 6
6 93 ...AACATTGGAG gtaaggggat... 4 511 6 ...tccattttag CAATGTCAAG... 7
7 82 ...AAAATACTGG gtatgtctta... 86 7 ...tcacttctag AGAATGGTAC... 8
8 83 ...AAAAATTTAG gtaaagatat... 110 8 ...taacttctag GTTATCTTGG... 9
9 59 ...TGTTAGTGTG gtaagtgatg... 834 9 ...ctgagtctag GTGATTTACA... 10
10 276 ...CAACTCCCGG gtaagtgagc... 132 10 ...tgtttttcag ACGGCCTATG... 11
11 80 ...AACTTAAAGA gtaaggcagc... 1 284 11 ...ctttttccag TCGGTCCCGG... 12
12 101 ...ACCTTCTATG gtaggtcact... 1 730 12 ...cctgttgtag GAGAAGTTGA... 13
13 125 ...CCTCTTCCCA gtaagtacat... 5 620 13 ...cttgtttaag ATTCGTACAT... 14
14 145 ...GGATTCATAG gtgagtttca... 876 14 ...gtcttctcag GGGCTTCTTC... 15
15 98 ...AAAGGTCGGG gtaagtaaac... 1 507 15 ...tgaattacag GCTTTAATTT... 16
16 2 043 ...TTCAAATGAC
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pared to the levels in the liver. The size of the mRNA
is 4 kb. ATA3 mRNA is not detectable in the brain,
colon, heart, lung, skeletal muscle, placenta, small
intestine, spleen, stomach, and testis.
Since ATA3 is a subtype of system A [25], we ¢rst
assessed the ability of hATA3 to transport MeAIB,
the model substrate for system A. When measured at
pH 8.5 in the presence of NaCl, the uptake of
MeAIB was signi¢cantly higher in hATA3 cDNA-
transfected cells than in vector-transfected cells
(Fig. 2). However, the cDNA-induced increase was
surprisingly small (approx. 50%). Under identical
conditions, MeAIB uptake was increased much
more markedly by hATA1 (8-fold) and hATA2
(11-fold). We also compared hATA3 with hATA1
and hATA2 for the ability to transport glycine. Gly-
cine uptake was increased 4-fold by hATA3. The
ability of hATA1 to increase glycine uptake was sim-
ilar to that of hATA3. hATA2 was, however, able
to increase glycine uptake to a much higher level
Fig. 3. pH dependence (A) and Na activation kinetics (B) of
hATA3-mediated glycine transport. (A) HRPE cells were trans-
fected with either pSPORT alone (b) or hATA3 cDNA (a).
Transport of [3H]glycine (20 WM) was measured in these cells
at 37‡C for 15 min in the presence of NaCl. pH of the trans-
port bu¡er was changed from 5.5 to 9.0 as indicated. Values
are means þ S.E. from four determinations. (B) HRPE cells
were transfected with either pSPORT alone or hATA3 cDNA.
Transport of [3H]glycine (20 WM) was measured in these cells
at 37‡C for 15 min in the presence of varying concentrations of
NaCl (5^140 mM). NaCl was replaced isoosmotically with
NMDG chloride as required. pH of the transport bu¡er was
8.5. Data represent only hATA3-speci¢c transport which was
calculated by subtracting the transport in pSPORT-transfected
cells from the transport in hATA3 cDNA-transfected cells. Val-
ues are means þ S.E. from four determinations.
Fig. 2. Transport of MeAIB and glycine by hATA3, hATA1
and hATA2. HRPE cells were transfected with pSPORT alone,
hATA3 cDNA, hATA1 cDNA, or hATA2 cDNA. The cDNAs
were expressed by vaccinia virus expression system. Transport
of [14C]MeAIB (20 WM) and [3H]glycine (20 WM) was measured
in these cells at 37‡C for 15 min in the presence of NaCl (pH
8.5). Values are means þ S.E. from four determinations.
Fig. 1. Northern blot analysis of ATA3-speci¢c mRNA in hu-
man tissues. A commercially available hybridization-ready blot
containing poly(A)mRNA (2 Wg per lane) from 12 di¡erent
human tissues was sequentially hybridized with 32P-labeled
hATA3 cDNA and then with 32P-labeled glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA under high strin-
gency conditions. The sizes of the hybridization-positive signals
are indicated. Lanes 1^12 represent brain, colon, heart, kidney,
liver, lung, skeletal muscle, placenta, small intestine, spleen,
stomach, and testis, respectively.
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(9-fold). These data show that hATA3 is an authen-
tic member of the system A subfamily due to its
ability to mediate MeAIB uptake. However, this
newly identi¢ed system A transporter is clearly less
e¡ective than hATA1 and hATA2 in handling this
model substrate.
We used glycine as a substrate for further func-
tional characterization of this transporter. Fig. 3 de-
scribes the pH dependence and Na activation ki-
netics of hATA3-mediated glycine uptake. The
transport function of hATA3 with glycine as the
substrate was markedly in£uenced by the pH of
transport bu¡er. The transport function was negli-
gible at pH 6.5, but it increased dramatically when
the pH of transport bu¡er was increased above 6.5.
The hATA3-speci¢c transport was maximal at pH
8.5. There was a 6-fold increase in hATA3-speci¢c
glycine transport when pH was changed from 7 to
8.5. The transport function of hATA3 was obligato-
rily dependent on the presence of Na. hATA3 was
non-functional when Na was replaced with NMDG
(data not shown). The relationship between Na
concentration and hATA3-speci¢c glycine uptake
was hyperbolic over the range of 5^140 mM. The
transport was saturable with increasing concentra-
tions of glycine (data not shown) and the Michae-
lis-Menten constant (Kt) was 1.6 þ 0.3 mM.
We then investigated the substrate speci¢city of
hATA3 by assessing the ability of various amino
acids to inhibit hATA3-speci¢c uptake of [3H]glycine
(20 WM) (Table 2). At a concentration of 2.5 mM, all
neutral amino acids tested showed marked inhibi-
tion. Histidine was the most potent inhibitor whereas
leucine and phenylalanine were the least potent. Glu-
tamine showed about 50% inhibition. The inhibition
by MeAIB was only 30%. The anionic amino acids
did not show any inhibition. The most surprising
¢nding was that the cationic amino acids arginine
and lysine were very potent inhibitors. The inhibition
caused by these two amino acids (60^70%) was much
higher than the inhibition caused by MeAIB, gluta-
mine, proline, glycine, asparagine, and serine. This
was an unexpected ¢nding because there is no evi-
dence in the literature for any signi¢cant interaction
of system A with cationic amino acids. Moreover,
the previously cloned ATA1 and ATA2 have shown
no or little a⁄nity for cationic amino acids. But, the
present data show that hATA3 exhibits much higher
a⁄nity for cationic amino acids than for most neu-
tral amino acids.
Table 2
Inhibition of hATA3-speci¢c transport of [3H]glycine by other amino acids
Unlabeled amino acid hATA3 cDNA-speci¢c [3H]Gly transport
pmol/106 cells/15 min %
Control 1 701.8 þ 82.2 100
Serine 809.1 þ 52.0 48
Alanine 537.5 þ 16.4 32
MeAIB 1 205.6 þ 71.2 71
Glycine 737.7 þ 63.5 43
Glutamine 782.2 þ 41.1 46
Asparagine 637.0 þ 38.2 37
Proline 1 228.2 þ 76.7 72
Histidine 268.1 þ 24.3 16
Leucine 1 324.1 þ 71.6 78
Phenylalanine 1 383.1 þ 34.8 81
Arginine 528.0 þ 59.3 31
Lysine 665.7 þ 33.8 39
Glutamate 1 715.8 þ 115.4 101
HRPE cells were transfected with either pSPORT alone or pSPORT-hATA3 cDNA. Transport of [3H]glycine (20 WM) was measured
in these cells at 37‡C for 15 min in the presence of NaCl (pH 8.5). When present, the concentration of unlabeled amino acids was 2.5
mM. cDNA-speci¢c [3H]glycine transport was calculated by subtracting the transport in vector-transfected cells from the transport in
cDNA-transfected cells. Values are means þ S.E. from four determinations.
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In order to demonstrate that hATA3 does not
simply interact with cationic amino acids but it ac-
tually transports these amino acids, we studied di-
rectly the ability of hATA3 to mediate the uptake
of arginine. When measured in the presence of
Na, the uptake of arginine in cells transfected
with hATA3 cDNA was signi¢cantly higher than in
control cells transfected with vector alone (Fig. 4).
Surprisingly, the hATA3-speci¢c uptake was ob-
served at all pH values within the pH range 5.5^
9.0. The lack of pH dependence of hATA3-speci¢c
arginine uptake is in contrast to the marked pH de-
pendence of glycine uptake mediated by the same
transporter. Another interesting di¡erence between
arginine uptake and glycine uptake via hATA3 is
the involvement of Na in the transport process.
hATA3-speci¢c arginine uptake was not dependent
on Na (Fig. 4). The transport was saturable with
increasing concentrations of arginine (data not
shown) with a Kt of 0.30 þ 0.04 mM.
We then investigated the substrate speci¢city of
hATA3 with [3H]arginine as the substrate. The abil-
ity of various amino acids (2.5 mM) to compete with
[3H]arginine (20 WM) for the hATA3-mediated up-
take process was assessed in the presence of NaCl
(data not shown). The cationic amino acids arginine
and lysine were the most potent inhibitors of
[3H]arginine uptake, followed by neutral amino
acids. Again, neutral amino acids such as alanine,
serine, histidine, asparagine and glutamine were less
e¡ective than cationic amino acids in competing with
[3H]arginine uptake via hATA3. These data show
clearly that hATA3 has higher a⁄nity for cationic
amino acids than for neutral amino acids.
hATA3 is structurally similar to the members of
the system A subfamily and therefore it is expected
to interact with MeAIB, the model substrate for sys-
tem A. ATA1^3 form a subgroup within the gluta-
mine transporter family and therefore hATA3 is also
expected to interact with glutamine similar to ATA1
and ATA2. To determine the a⁄nities of hATA3 for
MeAIB and glutamine, we assessed the potencies of
these amino acids to inhibit hATA3-speci¢c glycine
uptake. The uptake was inhibited by both amino
acids. The IC50 values (i.e., concentration of the in-
hibitor necessary for 50% inhibition) were 6.7 þ 0.8
and 2.5 þ 0.5 mM for MeAIB and glutamine, respec-
tively. Thus, hATA3 does interact with glutamine
and MeAIB as expected of a member of the system
A subfamily, but the a⁄nity of the transporter for
these two neutral amino acids is signi¢cantly less
than the a⁄nity for arginine (0.30 þ 0.04 mM).
ATA3 reported in this paper is a novel transporter
with functional and physiological signi¢cance. This is
the ¢rst transporter in the glutamine transporter
family that interacts with not only neutral amino
acids but also with cationic amino acids. Since
ATA3 mediates Na-dependent transport of MeAIB,
it is functionally related to amino acid transport sys-
tem A. The interaction of ATA3 with cationic amino
acids with high a⁄nity came as a surprise because
Fig. 4. pH dependence (A) and Na independence (B) of
hATA3-mediated arginine transport. (A) HRPE cells were
transfected with either pSPORT alone (b) or hATA3 cDNA
(a). Transport of [3H]arginine (20 WM) was measured in these
cells at 37‡C for 15 min in the presence of NaCl. pH of the
transport bu¡er was changed from 5.5 to 9.0 as indicated. Val-
ues are means þ S.E. from four determinations. (B) HRPE cells
were transfected with either pSPORT alone or hATA3 cDNA.
Transport of [3H]arginine (20 WM) was measured in these cells
at 37‡C for 15 min in the presence of varying concentrations of
NaCl (5^140 mM). NaCl was replaced isoosmotically with
NMDG chloride as required. pH of the transport bu¡er was
8.5. Data represent only hATA3-speci¢c transport which was
calculated by subtracting the transport in pSPORT-transfected
cells from the transport in hATA3 cDNA-transfected cells. Val-
ues are means þ S.E. from four determinations.
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system A has never been shown to mediate the trans-
port of cationic amino acids. The failure to detect
this novel subtype of system A in earlier studies
may be due to several reasons. This transporter is
expressed almost exclusively in the liver and there-
fore studies of system A in tissues other than the
liver would not detect a system A that interacts
with cationic amino acids. There have been numer-
ous studies of system A in the liver [27,28]. Since the
liver expresses not only ATA3 but also ATA2, it is
possible that this co-expression masked the transport
function of ATA3 in earlier studies.
Even though ATA3 mediates Na-dependent
transport of MeAIB and is structurally related to
ATA1 and ATA2, there are several important func-
tional and structural characteristics that are unique
to ATA3. ATA3 does transport MeAIB, but its af-
¢nity for this system A model substrate is very low.
ATA1 [19,20] and ATA2 [21^24] recognize MeAIB
with a Kt value of 0.2^0.4 mM. In contrast, the Kt
value for hATA3 for interaction with MeAIB is
about 20-fold higher (6.7 mM). Because of this
marked di¡erence in the a⁄nity between ATA2
and ATA3, it is likely that at concentrations usually
employed for transport measurements (6 25 WM),
MeAIB transport is predominantly mediated by
ATA2 in the liver in spite of the co-expression of
ATA2 and ATA3 in this tissue. MeAIB is used
widely as a model substrate for system A and there-
fore previous studies with this substrate were unable
to detect MeAIB transport in liver cells that was
sensitive to inhibition by cationic amino acids. A
comparison of data related to the interaction of sev-
eral neutral amino acids with hATA1 [20], hATA2
[22] and hATA3 (this study) suggests that the a⁄nity
of ATA3 for most of the neural amino acids is lower
than the a⁄nities of ATA1 and ATA2 for these ami-
no acids. This includes alanine, glycine, serine, pro-
line, glutamine, and asparagine. The most striking
functional di¡erence is in the interaction with cation-
ic amino acids. ATA1 and ATA2 do not interact
with arginine and lysine [20,22] whereas ATA3 is
able to recognize these amino acids as substrates.
Interestingly, the transport of neutral amino acids
via ATA3 is a Na-coupled process as is the case
with ATA1 and ATA2, but the transport of arginine
via ATA3 is not Na-dependent. Thus, ATA3 is a
Na-dependent transporter for MeAIB and other
neutral amino acids and a Na-independent trans-
porter for cationic amino acids. In this respect,
ATA3 is similar to CAT1 and yL.
The transport function of hATA3 is in£uenced
markedly by extracellular pH, but this e¡ect is seen
only with neutral amino acid substrates. The trans-
port of arginine via hATA3 is not in£uenced within
the pH range 6^9. This is in contrast to glycine trans-
port which is undetectable at pH 6 but becomes
robust at pH 8.5. We are unable to explain this in-
teresting phenomenon at present. The relative pro-
portion of cationic species and zwitterionic species
of arginine is expected to vary to some extent within
the pH range 6^9. Even if one assumes that the af-
¢nity of hATA3 is much greater for cationic species
than for zwitterionic species, the change in the rela-
tive proportion of these two ionic species of arginine
is expected to be small within the pH range and it is
not clear whether this change would su⁄ce to ac-
count for the lack of pH in£uence on arginine trans-
port.
Though hATA3 is able to transport MeAIB and
other neutral amino acids, it shows greater a⁄nity
for cationic amino acids than for neutral amino
acids. Arginine is transported by hATA3 with a Kt
value of 0.30 þ 0.4 mM. A comparison of Kt values
for arginine for various transporters that are capable
of arginine transport indicates that the a⁄nity of
hATA3 for arginine is similar to the a⁄nities of oth-
er transporters. The cationic amino acid transporters
CAT1^3 exhibit a Kt of 50^400 WM for arginine [1,2].
Similarly, the Kt for arginine for the transporters
b0;, yL and B0; is also in the range of 100^300
WM [10,13,15]. The Kt for arginine for hATA3 in the
present study is 300 WM.
The tissue expression pattern of ATA3 is unique
among the known members of the glutamine trans-
porter family. ATA3 is the only member of the fam-
ily that is expressed almost exclusively in the liver.
More importantly, ATA3 may be the major trans-
porter responsible for the uptake of cationic amino
acids in this tissue. Liver does not express any of the
other known cationic amino acid transporters. b0;
and yL are expressed primarily in the small intes-
tine and kidney [1^4]. The expression of B0; is re-
stricted to the lung and mammary gland [15]. The
members of the cationic amino acid transporter
gene family, though expressed more widely in mam-
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malian tissues, are not present in the liver [1^4]. To
date, the only cationic amino acid transporter that
has been shown to be expressed in the liver is
CAT2a, an alternative splice variant of CAT2
[1,2,29]. It is a low-a⁄nity transporter with a Kt
for arginine in the range of 2^5 mM. ATA3 that is
expressed abundantly in the liver has about 10-fold
higher a⁄nity for arginine compared to CAT2a.
Since ATA3 is expressed abundantly in the liver,
we speculate that this transporter provides the major
mechanism for the entry of arginine into hepatocytes
under physiological conditions.
We thank Ida Walker for expert secretarial assis-
tance. This work was supported by National Insti-
tutes of Health Grants DA10045, HD33347 and
HL64196.
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